Literature DB >> 9089832

Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation.

M A Dew1, J T Becker, J Sanchez, R Caldararo, O L Lopez, J Wess, S K Dorst, G Banks.   

Abstract

BACKGROUND: There is little agreement on whether the prevalence of psychiatric disorder is elevated in HIV-seropositive (HIV+) populations compared with uninfected persons. However, evaluation of this issue has been limited difficulties of sampling, study design and failure to control for other risk factors for disorder.
METHODS: Prevalence and clinical characteristics of DSM-III-R major depressive disorder (MDD), generalized anxiety disorder, adjustment disorder, and alcohol and substance abuse/dependence were evaluated in a representative sample of HIV+ men attending primary care physicians' offices in a defined geographical area. Lifetime prevalence at baseline and 1-year rates during longitudinal follow-up were determined for the 113 HIV+ men, as well as 57 HIV-men, via standardized interview. Multivariate analyses considered unique and combined effects of HIV serostatus and other risk factors on likelihood of disorder.
RESULTS: Although there were no differences in lifetime rates prior to baseline, HIV+ men were at greater risk for disorders during the prospective study period. For MDD, this effect was maintained even after controlling for other risk factors. Several of these other factors bore their own effects: regardless of HIV serostatus, men were susceptible to psychopathology if at baseline they were younger, had a lifetime psychiatric history, or had poor social supports or a low sense of personal mastery.
CONCLUSIONS: The risk of certain psychiatric disorders appears uniquely elevated in HIV+ men. Since other factors also influence risk, interventions designed to minimize psychopathology during HIV infection should attend to both HIV-related and non-HIV-related risk factors.

Entities:  

Mesh:

Year:  1997        PMID: 9089832     DOI: 10.1017/s0033291796004552

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  49 in total

1.  Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.

Authors:  Luiz F Ferrari; Jon D Levine
Journal:  Eur J Neurosci       Date:  2010-08-19       Impact factor: 3.386

Review 2.  Drug treatment of depression in HIV-positive patients : safety considerations.

Authors:  Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  INTERDEPENDENCE OF STRESS PROCESSES AMONG AFRICAN AMERICAN FAMILY MEMBERS: INFLUENCE OF HIV SEROSTATUS AND A NEW INFANT.

Authors:  Daniel J Feaster; Jose Szapocznik
Journal:  Psychol Health       Date:  2002

4.  The role of illness, resources, appraisal, and coping strategies in adjustment to HIV/AIDS: the direct and buffering effects.

Authors:  K I Pakenham; M Rinaldis
Journal:  J Behav Med       Date:  2001-06

Review 5.  Neuropsychiatric aspects of HIV infection among older adults.

Authors:  C H Hinkin; S A Castellon; J H Atkinson; K Goodkin
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

6.  Predictors of post-traumatic psychological growth in the late years after lung transplantation.

Authors:  Kristen R Fox; Donna M Posluszny; Andrea F DiMartini; Annette J DeVito Dabbs; Emily M Rosenberger; Rachelle A Zomak; Christian Bermudez; Mary Amanda Dew
Journal:  Clin Transplant       Date:  2014-04       Impact factor: 2.863

7.  A Cross-Sectional Study of Depressive Symptoms and Risky Alcohol Use Behaviors Among HIV Primary Care Patients in New York City.

Authors:  Yasemin Algur; Jennifer C Elliott; Efrat Aharonovich; Deborah S Hasin
Journal:  AIDS Behav       Date:  2018-05

8.  Perceived importance of five different health issues for gay and bisexual men: implications for new directions in health education and prevention.

Authors:  Christian Grov; Ana Ventuneac; H Jonathon Rendina; Ruben H Jimenez; Jeffrey T Parsons
Journal:  Am J Mens Health       Date:  2012-10-22

9.  Participants' perspectives on cognitive-behavioral therapy for adherence and depression in HIV.

Authors:  Carla Berg; Sudha Raminani; Joseph Greer; Meaghan Harwood; Steven Safren
Journal:  Psychother Res       Date:  2008-05

10.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.

Authors:  Steven A Safren; Conall O'Cleirigh; Judy Y Tan; Sudha R Raminani; Laura C Reilly; Michael W Otto; Kenneth H Mayer
Journal:  Health Psychol       Date:  2009-01       Impact factor: 4.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.